<SEC-DOCUMENT>0001607062-15-000271-index.html : 20150625 <SEC-HEADER>0001607062-15-000271.hdr.sgml : 20150625 <ACCEPTANCE-DATETIME>20150625144102 ACCESSION NUMBER: 0001607062-15-000271 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20150625 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150625 DATE AS OF CHANGE: 20150625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 15951578 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>gnbt082515form8k.htm <DESCRIPTION>FORM 8-K <TEXT> Document 1 - file: gnbt082515form8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-3.1 <SEQUENCE>2 <FILENAME>ex3_1.htm <DESCRIPTION>EXHIBIT 3.1 <TEXT> Document 2 - file: ex3_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>3 <FILENAME>ex4_1.htm <DESCRIPTION>EXHIBIT 4.1 <TEXT> Document 3 - file: ex4_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.2 <SEQUENCE>4 <FILENAME>ex4_2.htm <DESCRIPTION>EXHIBIT 4.2 <TEXT> Document 4 - file: ex4_2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.3 <SEQUENCE>5 <FILENAME>ex4_3.htm <DESCRIPTION>EXHIBIT 4.3 <TEXT> Document 5 - file: ex4_3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>6 <FILENAME>ex99_1.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 6 - file: ex99_1.htm
</DOCUMENT> </SEC-DOCUMENT>